Strasbourg cohort of people with adrenal cortical carcinoma
Characterization of the Strasbourg Cohort of Patients With Adrenal Cortex Carcinoma
This project collects clinical, imaging and pathology information from adults treated at Strasbourg University Hospital to better understand adrenal cortical carcinoma.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT07335679 on ClinicalTrials.gov |
What this trial studies
This observational cohort compiles retrospective and prospective clinical, imaging, biochemical and histopathologic data from adults diagnosed with adrenal cortical carcinoma and followed at Strasbourg University Hospital between January 1, 2000 and May 31, 2025. Inclusion requires histopathologic confirmation of the adrenal cortical tumor and excludes tumors later reclassified as non-ACC. Collected data will include Weiss score, Ki-67, hormonal secretion status, imaging features, treatments and outcomes. The work is purely descriptive and aims to define disease patterns and prognostic markers to inform future research and clinical decisions.
Who should consider this trial
Good fit: Adults (≥18 years) with histopathologically confirmed adrenal cortical carcinoma who are or were followed at Strasbourg University Hospital between January 1, 2000 and May 31, 2025 are eligible.
Not a fit: Patients whose tumors were reclassified as non-ACC, individuals not followed at Strasbourg University Hospital, and pediatric patients are unlikely to benefit from participation.
Why it matters
Potential benefit: If successful, this cohort could improve understanding of tumor biology and outcomes to help doctors diagnose, prognose and design future trials for ACC.
How similar studies have performed: Previous single-center and registry cohorts have yielded useful descriptive data on ACC but are limited by rarity of the disease, so this project builds on existing observational work rather than introducing a novel intervention.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult subject (≥ 18 years old) * Subjects followed at Strasbourg University Hospital for adrenal cortical carcinoma diagnosed between January 1, 2000, and May 31, 2025 Exclusion Criteria: \- Tumor reclassified as non-SCC by histopathology
Where this trial is running
Strasbourg
- Service d'Endocrinologie, Diabétologie, Nutrition - CHU de Strasbourg - France — Strasbourg, France (Recruiting)
Study contacts
- Study coordinator: Philippe BALTZINGER, MD
- Email: philippe.baltzinger@chru-strasbourg.fr
- Phone: 33 3 88 12 75 82
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.